Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass balance study of oral docetaxel with ritonavir
NL-OMON35601Active, not recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Oct 2011
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of docetaxel and ritonavir in cancer, sponsored by Netherlands Cancer Institute. Primary endpoint: Pharmacokinetics and mass balance of docetaxel. Started Oct 2011; status: active, not recruiting.
02
Drugs
docetaxelritonavir
03
Conditions
cancer
Beyond the preview
Go deeper on NL-OMON35601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35601.